Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
17.07
+0.85 (5.24%)
Mar 10, 2026, 9:55 AM CST

SHA:688488 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
6,8256,8713,3075,2644,4276,539
Upgrade
Market Cap Growth
115.12%107.76%-37.17%18.91%-32.31%-37.22%
Upgrade
Enterprise Value
6,9927,0393,4025,1474,0845,910
Upgrade
Last Close Price
16.2216.337.8612.5110.5415.57
Upgrade
PS Ratio
9.479.547.9212.8018.1325.57
Upgrade
PB Ratio
6.316.353.104.683.694.99
Upgrade
P/TBV Ratio
10.5610.635.225.284.145.60
Upgrade
EV/Sales Ratio
9.709.778.1412.5116.7223.11
Upgrade
EV/EBITDA Ratio
73.4573.94----
Upgrade
EV/EBIT Ratio
146.45147.42----
Upgrade
Debt / Equity Ratio
0.450.450.460.370.170.00
Upgrade
Debt / EBITDA Ratio
5.095.09----
Upgrade
Net Debt / Equity Ratio
0.060.060.04-0.03-0.23-0.46
Upgrade
Net Debt / EBITDA Ratio
0.670.67-0.450.452.0117.11
Upgrade
Net Debt / FCF Ratio
---0.570.121.195.60
Upgrade
Asset Turnover
--0.230.240.160.18
Upgrade
Inventory Turnover
--1.021.441.271.79
Upgrade
Quick Ratio
--0.931.321.877.52
Upgrade
Current Ratio
--1.381.782.428.94
Upgrade
Return on Equity (ROE)
-1.84%-1.84%-12.66%-6.54%-9.89%-2.25%
Upgrade
Return on Assets (ROA)
---5.24%-3.90%-6.94%-2.70%
Upgrade
Return on Invested Capital (ROIC)
-3.38%-3.43%-13.71%-10.53%-21.05%-9.64%
Upgrade
Return on Capital Employed (ROCE)
---12.40%-8.50%-13.00%-4.60%
Upgrade
Earnings Yield
-0.29%-0.29%-4.27%-1.44%-2.80%-0.46%
Upgrade
FCF Yield
---2.48%-4.51%-5.26%-1.64%
Upgrade
Buyback Yield / Dilution
4.97%6.20%0.44%-2.17%3.44%-7.71%
Upgrade
Total Shareholder Return
4.97%6.20%0.44%-2.17%3.44%-7.71%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.